- Home
- Publications
- Publication Search
- Publication Details
Title
Microscaled proteogenomic methods for precision oncology
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-27
DOI
10.1038/s41467-020-14381-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accurate quantitative proteomic analyses using metabolic labeling and High Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS)
- (2019) Sibylle Pfammatter et al. JOURNAL OF PROTEOME RESEARCH
- Characterization and Optimization of Multiplexed Quantitative Analyses Using High-Field Asymmetric-Waveform Ion Mobility Mass Spectrometry
- (2019) Devin K. Schweppe et al. ANALYTICAL CHEMISTRY
- Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
- (2019) Suhas Vasaikar et al. CELL
- TMT labeling for the masses: A robust and cost-efficient, in-solution labeling approach
- (2019) Jana Zecha et al. MOLECULAR & CELLULAR PROTEOMICS
- Comprehensive Single-Shot Proteomics with FAIMS on a Hybrid Orbitrap Mass Spectrometer
- (2018) Alexander S. Hebert et al. ANALYTICAL CHEMISTRY
- Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
- (2018) Filip Mundt et al. CANCER RESEARCH
- Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry
- (2018) Philipp Mertins et al. Nature Protocols
- Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
- (2018) Tenley C. Archer et al. CANCER CELL
- Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast
- (2018) Clare D'Arcy et al. JOURNAL OF CLINICAL PATHOLOGY
- A curated resource for phosphosite-specific signature analysis
- (2018) Karsten Krug et al. MOLECULAR & CELLULAR PROTEOMICS
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition
- (2018) H. Rudolf de Boer et al. ONCOGENE
- DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer
- (2018) Ryoichi Matsunuma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1
- (2018) Masashi Namba et al. CANCER LETTERS
- Quantitative Proteomic Analysis of Optimal Cutting Temperature (OCT) Embedded Core-Needle Biopsy of Lung Cancer
- (2017) Xiaozheng Zhao et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
- (2017) Michael A. Gordon et al. MOLECULAR CANCER THERAPEUTICS
- MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701
- (2017) Chia-Hung Chen et al. Molecular Oncology
- Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
- (2017) Kuan-lin Huang et al. Nature Communications
- Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents
- (2017) Leila Farahmand et al. CURRENT CANCER DRUG TARGETS
- Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors
- (2017) Charles Caldwell et al. Scientific Reports
- The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
- (2016) Jennifer L. Hsu et al. CANCER AND METASTASIS REVIEWS
- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer
- (2016) María F. Mercogliano et al. CLINICAL CANCER RESEARCH
- Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction
- (2016) Jing Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- Proteogenomics connects somatic mutations to signalling in breast cancer
- (2016) Philipp Mertins et al. NATURE
- Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient
- (2016) Eva Dazert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
- (2016) Anthony Ferrari et al. Nature Communications
- Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab
- (2016) Sherene Loi et al. JAMA Oncology
- Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps
- (2015) Tiannan Guo et al. NATURE MEDICINE
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- CopywriteR: DNA copy number detection from off-target sequence data
- (2015) Thomas Kuilman et al. GENOME BIOLOGY
- Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Proteogenomic characterization of human colon and rectal cancer
- (2014) Bing Zhang et al. NATURE
- Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
- (2013) D Raina et al. ONCOGENE
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- (2013) Shunqiang Li et al. Cell Reports
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
- (2012) Thuy Vu et al. Frontiers in Oncology
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now